✦ LIBER ✦

HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin

✍ Scribed by C.-W. Tseng; Y.-H. Hsieh; C.-K. Chang; N.-S. Lai; T.-H. Hung; S. -F. Wu; K.-C. Tseng

Book ID: 117948331
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 507 KB
Volume: 80
Category: Article
ISSN: 0001-2815
DOI: 10.1111/j.1399-0039.2012.01956.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neutrophil Function and Apoptosis in Pat

Neutrophil Function and Apoptosis in Patients with Chronic Hepatitis C Treated with Pegylated Interferon α and Ribavirin

✍ Elżbieta Jabłonowska; Kamila Wójcik; Barbara Kur; Przemysław Lewkowicz; Marek No 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 417 KB

Factors associated with hemolytic anemia

Factors associated with hemolytic anemia in patients with chronic hepatitis C treated with combination of interferon and ribavirin

✍ Cheng Hou; M.L. Yu; C.Y. Dai; W.L. Chuang; S.C. Chen; Z.Y. Lin; L.Y. Wang; W.Y. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Pegylated interferon and ribavirin assoc

Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C

✍ C. Burgueño-Montañés; R. Pérez-Álvarez 📂 Article 📅 2011 🏛 Elsevier ⚖ 308 KB

Iatrogenic hyperpigmentation in chronica

Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin

✍ Jennifer Lin; Jason P. Lott; Valerianna K. Amorosa; Carrie L. Kovarik 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Anti-interferon-α neutralizing antibody

Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C

✍ F. Matsuda; Y. Torii; H. Enomoto; C. Kuga; N. Aizawa; Y. Iwata; M. Saito; H. Ima 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca